National and regional population-based registries are, provided diagnostic accuracy and full
coverage of the target population, indispensible tools for epidemiological research. Chronic …

Background More effective treatments have become available for haematological
malignancies from the early 2000s, but few large-scale population-based studies have …

Clinical management guidelines on malignant disorders are generally based on data from
clinical trials with selected patient cohorts. In Sweden, more than 95% of all patients …

Background Adulthood acute lymphoblastic leukemia (ALL) is a rare disease. In contrast to
childhood ALL, survival for adults with ALL is poor. Recently, new protocols, including use of …

Survival has increased dramatically for patients with chronic phase chronic myeloid
leukemia (CP-CML) using BCR-ABL targeted tyrosine kinase inhibitors, such that life …

BACKGROUND Outcomes for patients with chronic myeloid leukemia (CML) have improved
after the advent of tyrosine kinase inhibitors (TKIs), which target the BCR/ABL fusion gene …

Objectives To examine contemporary survival patterns in the general population of patients
diagnosed with chronic myeloid leukaemia (CML), and to identify patient groups with less …

Background Recent population-based studies in the United States of America (USA) and
other countries have shown improvements in survival for patients with chronic lymphocytic …

Evaluations of the 'real-world'efficacy and safety of tyrosine kinase inhibitors in patients with
chronic myeloid leukemia are scarce. A nationwide, population-based, chronic myeloid …

Objective To assess the impact and results of treatment of CML in the general population,
we conducted a population‐based, nationwide study on 3585 CML patients diagnosed …